HealthStream Inc (HSTM) is a publicly traded Healthcare sector company. As of May 21, 2026, HSTM trades at $23.88 with a market cap of $694.15M and a P/E ratio of 36.26. HSTM moved -2.03% today. Year to date, HSTM is +3.86%; over the trailing twelve months it is -16.51%. Its 52-week range spans $19.50 to $34.24. Analyst consensus is buy with an average price target of $32.00. Rallies surfaces HSTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading HSTM stock inside the company?
Recent HSTM insider activity includes O'Hara Kevin P sold 3.00K, Cunningham Jeff sold 2.10K, O'Hara Kevin P sold 2.00K, and Taylor Tate Deborah sold 1.58K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
HSTM Key Metrics
Key financial metrics for HSTM
Metric
Value
Price
$23.88
Market Cap
$694.15M
P/E Ratio
36.26
EPS
$0.67
Dividend Yield
0.04%
52-Week High
$34.24
52-Week Low
$19.50
Volume
16
Avg Volume
0
Revenue (TTM)
$311.78M
Net Income
$19.92M
Gross Margin
0.00%
Recent HSTM Insider Trades
O'Hara Kevin P sold 3.00K (~$72.23K) on May 20, 2026.
Cunningham Jeff sold 2.10K (~$50.59K) on Dec 10, 2025.
O'Hara Kevin P sold 2.00K (~$48.52K) on Dec 8, 2025.
Taylor Tate Deborah sold 1.58K (~$40.23K) on Nov 26, 2025.
Recent HSTM insider activity includes O'Hara Kevin P sold 3.00K, Cunningham Jeff sold 2.10K, O'Hara Kevin P sold 2.00K, and Taylor Tate Deborah sold 1.58K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for HSTM?
Yes. Rallies tracks HSTM insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is HSTM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for HSTM. It does not provide personalized investment advice.
